However, a genetic difference that impairs interferon gamma (IFNγ) immune response resulting in unusually severe disease on encountering specific infections, such as the mycobacteria causing tuberculosis [3, 7, 8], has also recently been found relevant to COVID-19 [7, 9]. This evidence concerns the gene IFNG and COVID-19.